Mellstedt H - Search Results

1

Mellstedt H. Mellstedt H. Drugs Today (Barc). 2003;39 Suppl C:1-16. Drugs Today (Barc). 2003. PMID: 14988743 Review.

2

Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma.

Osterborg A, Henriksson L, Mellstedt H. Osterborg A, et al. Among authors: mellstedt h. Acta Oncol. 2000;39(7):797-800. doi: 10.1080/028418600750063523. Acta Oncol. 2000. PMID: 11145435

3

Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.

Aguilar-Santelises M, Rottenberg ME, Lewin N, Mellstedt H, Jondal M. Aguilar-Santelises M, et al. Among authors: mellstedt h. Int J Cancer. 1996 Apr 22;69(2):114-9. doi: 10.1002/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3. Int J Cancer. 1996. PMID: 8608978

4

Normal colon of Sprague-Dawley rats. An immunohistochemical study.

Shetye JD, Rubio CA, Mellstedt HT. Shetye JD, et al. Among authors: mellstedt ht. Anat Embryol (Berl). 1992;185(1):69-76. doi: 10.1007/BF00213602. Anat Embryol (Berl). 1992. PMID: 1736686

5

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

Daneshmanesh AH, Hojjat-Farsangi M, Khan AS, Jeddi-Tehrani M, Akhondi MM, Bayat AA, Ghods R, Mahmoudi AR, Hadavi R, Österborg A, Shokri F, Rabbani H, Mellstedt H. Daneshmanesh AH, et al. Among authors: mellstedt h. Leukemia. 2012 Jun;26(6):1348-55. doi: 10.1038/leu.2011.362. Epub 2012 Jan 6. Leukemia. 2012. PMID: 22289919

6

Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation.

Ullenhag G, Bird C, Ragnhammar P, Frödin JE, Strigård K, OIsterborg A, Thorpe R, Mellstedt H, Wadhwa M. Ullenhag G, et al. Among authors: mellstedt h. Clin Immunol. 2001 Apr;99(1):65-74. doi: 10.1006/clim.2000.4999. Clin Immunol. 2001. PMID: 11286542

7

Monoclonal antibodies as enhancers of the host's immunoresponse against the tumour.

Mellstedt H. Mellstedt H. Ann Oncol. 2000;11 Suppl 3:191-4. doi: 10.1093/annonc/11.suppl_3.191. Ann Oncol. 2000. PMID: 11079140 Review. No abstract available.

8

Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma.

Mosolits S, Harmenberg U, Rudén U, Ohman L, Nilsson B, Wahren B, Fagerberg J, Mellstedt H. Mosolits S, et al. Among authors: mellstedt h. Cancer Immunol Immunother. 1999 Feb;47(6):315-20. doi: 10.1007/s002620050536. Cancer Immunol Immunother. 1999. PMID: 10203061

9

T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma.

Fagerberg J, Yi Q, Gigliotti D, Harmenberg U, Rudén U, Persson B, Osterborg A, Mellstedt H. Fagerberg J, et al. Among authors: mellstedt h. Int J Cancer. 1999 Mar 1;80(5):671-80. doi: 10.1002/(sici)1097-0215(19990301)80:5<671::aid-ijc7>3.0.co;2-e. Int J Cancer. 1999. PMID: 10048965

10

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen.

Samanci A, Yi Q, Fagerberg J, Strigård K, Smith G, Rudén U, Wahren B, Mellstedt H. Samanci A, et al. Among authors: mellstedt h. Cancer Immunol Immunother. 1998 Nov;47(3):131-42. doi: 10.1007/s002620050513. Cancer Immunol Immunother. 1998. PMID: 9829838 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results